$58.020
+0.041 (+0.07%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RAPT Prediction & Forecast by Similar Chart Analysis
Alphio's RAPT stock price prediction model matches the current RAPT Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $58.37 (+0.61%). The 1-week path is $59.33 (+2.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy RAPT Therapeutics Inc Stock?
RAPT Therapeutics is not a good buy for a beginner, long-term investor at this time. The stock is trading near its acquisition price of $58 per share, and the upside potential is minimal due to the finalized acquisition agreement with GSK. Analysts have downgraded the stock to neutral or hold ratings, and there are no significant catalysts or growth opportunities in the near term.
RAPT stock price ended at $58.02 on Monday, after rising +0.07%
RAPT Therapeutics Inc (RAPT) last closed at $58.02, gaining +0.07%. These facts feed the 1-day and 1-week RAPT price prediction above.
Forecast Drivers
RAPT Therapeutics Inc (RAPT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RAPT, ranked by similarity.
Seasonality analysis for RAPT
Historically the probability of a positive August return for RAPT is 0.00%. February offers the highest probability of a positive month at 53.45%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RAPT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $12.03 | $13.59 | $16.04 | -76.58% |
| Sep 2026 | $9.36 | $10.42 | $11.26 | -82.03% |
| Oct 2026 | $12.03 | $14.10 | $14.66 | -75.69% |
| Nov 2026 | $8.14 | $10.69 | $13.43 | -81.57% |
| Dec 2026 | $10.37 | $10.42 | $11.65 | -82.03% |
In 2026, RAPT Therapeutics Inc (RAPT) is projected to range from $8.14 to $16.04.
RAPT Therapeutics Inc 2026 monthly forecast
In Aug 2026, RAPT Therapeutics Inc is projected to average $13.59, with a low of $12.03 and high of $16.04.
In Sep 2026, RAPT Therapeutics Inc is projected to average $10.42, with a low of $9.36 and high of $11.26.
In Oct 2026, RAPT Therapeutics Inc is projected to average $14.10, with a low of $12.03 and high of $14.66.
In Nov 2026, RAPT Therapeutics Inc is projected to average $10.69, with a low of $8.14 and high of $13.43.
In Dec 2026, RAPT Therapeutics Inc is projected to average $10.42, with a low of $10.37 and high of $11.65.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.